CA Patent

CA2789798C — Oral formulations and lipophilic salts of methylnaltrexone

Assigned to Wyeth LLC · Expires 2020-09-22 · 6y expired

What this patent protects

The present invention provides compositions comprising a mixture of methylnaltrexone and sodium dodecyl sulfate, and compositions and formulations thereof, for oral administration.

USPTO Abstract

The present invention provides compositions comprising a mixture of methylnaltrexone and sodium dodecyl sulfate, and compositions and formulations thereof, for oral administration.

Drugs covered by this patent

Patent Metadata

Patent number
CA2789798C
Jurisdiction
CA
Classification
—
Expires
2020-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.